The influence of genetic factors on the osteoinductive potential of calcium phosphate ceramics in mice.
暂无分享,去创建一个
L. Donahue | C. V. van Blitterswijk | J. de Boer | Huipin Yuan | J. van der Stok | A. Barradas | H. Fernandes | M. Hogenes | K. Shultz | Bach Le Quang | Anindita Chaterjea | Hugo Fernandes
[1] M. Barbeck,et al. The chemical composition of synthetic bone substitutes influences tissue reactions in vivo: histological and histomorphometrical analysis of the cellular inflammatory response to hydroxyapatite, beta-tricalcium phosphate and biphasic calcium phosphate ceramics , 2012, Biomedical materials.
[2] F. Sailhan,et al. The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating. , 2011, Biomaterials.
[3] M. Yaqoob,et al. Ca2+ Influx through Reverse Mode Na+/Ca2+ Exchange Is Critical for Vascular Endothelial Growth Factor-mediated Extracellular Signal-regulated Kinase (ERK) 1/2 Activation and Angiogenic Functions of Human Endothelial Cells* , 2011, The Journal of Biological Chemistry.
[4] J. Hilborn,et al. Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: a study on ectopic bone formation in rats. , 2011, Acta biomaterialia.
[5] Xing‐dong Zhang,et al. Osteoinduction by Ca-P biomaterials implanted into the muscles of mice , 2011, Journal of Zhejiang University SCIENCE B.
[6] Bradley K Weiner,et al. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.
[7] K. Bessho,et al. Experimental study of osteoinduction using a new material as a carrier for bone morphogenetic protein-2. , 2011, The British journal of oral & maxillofacial surgery.
[8] Huipin Yuan,et al. BIOMATERIALS : CURRENT KNOWLEDGE OF PROPERTIES , EXPERIMENTAL MODELS AND BIOLOGICAL MECHANISMS , 2011 .
[9] Nicole J. Crane,et al. Heterotopic ossification following combat-related trauma. , 2010, The Journal of bone and joint surgery. American volume.
[10] J. Kessler,et al. Animal Models of Typical Heterotopic Ossification , 2010, Journal of biomedicine & biotechnology.
[11] R. Klar,et al. Synergistic induction of bone formation by hOP-1, hTGF-beta3 and inhibition by zoledronate in macroporous coral-derived hydroxyapatites. , 2010, Biomaterials.
[12] Huipin Yuan,et al. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting , 2010, Proceedings of the National Academy of Sciences.
[13] H. Kwon,et al. A Novel Ca2+/Calmodulin Antagonist HBC Inhibits Angiogenesis and Down-regulates Hypoxia-inducible Factor* , 2010, The Journal of Biological Chemistry.
[14] J. Sohier,et al. Macrophage and osteoblast responses to biphasic calcium phosphate microparticles. , 2009, Journal of biomedical materials research. Part A.
[15] E. Baird,et al. Prophylaxis of heterotopic ossification – an updated review , 2009, Journal of orthopaedic surgery and research.
[16] M. Manigrasso,et al. Comparison of Fracture Healing Among Different Inbred Mouse Strains , 2008, Calcified Tissue International.
[17] Chaojun Li,et al. Calmodulin is essential for angiogenesis in response to hypoxic stress in endothelial cells , 2007, Cell biology international.
[18] C. V. van Blitterswijk,et al. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. , 2006, Tissue engineering.
[19] T. Anada,et al. Elevated extracellular calcium stimulates secretion of bone morphogenetic protein 2 by a macrophage cell line. , 2006, Biochemical and biophysical research communications.
[20] Y. Tabata,et al. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. , 2005, Biomaterials.
[21] Huipin Yuan,et al. 3D microenvironment as essential element for osteoinduction by biomaterials. , 2005, Biomaterials.
[22] J. Jansen,et al. Ectopic bone formation in rats: the importance of vascularity of the acceptor site. , 2004, Biomaterials.
[23] Kazutoshi Nozaki,et al. A new bone‐inducing biodegradable porous β‐tricalcium phosphate , 2004 .
[24] 王满宜,et al. Heterotopic ossification , 2004 .
[25] R. J. Dumont,et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat , 2003, Gene Therapy.
[26] P. Layrolle,et al. Macroporous biphasic calcium phosphate scaffold with high permeability/porosity ratio. , 2003, Tissue engineering.
[27] Huipin Yuan,et al. A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats , 2002, Journal of materials science. Materials in medicine.
[28] S. Narumiya,et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Mohan,et al. Genetic variation in bone-regenerative capacity among inbred strains of mice. , 2001, Bone.
[30] P. Thomsen,et al. Macrophage interactions with modified material surfaces , 2001 .
[31] K. Nakao,et al. Crucial Involvement of the EP4 Subtype of Prostaglandin E Receptor in Osteoclast Formation by Proinflammatory Cytokines and Lipopolysaccharide , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] I. Lukić,et al. Genetic variability of new bone induction in mice. , 1999, Bone.
[33] Xing‐dong Zhang,et al. Osteoinduction by calcium phosphate biomaterials , 1998, Journal of materials science. Materials in medicine.
[34] A Odgaard,et al. Three-dimensional methods for quantification of cancellous bone architecture. , 1997, Bone.
[35] D. Mukhopadhyay,et al. Depletion of [Ca2+]i inhibits hypoxia-induced vascular permeability factor (vascular endothelial growth factor) gene expression. , 1996, Biochemical and biophysical research communications.
[36] W. Tong,et al. Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animals. , 1996, Biomaterials.
[37] L. Donahue,et al. Genetic variability in adult bone density among inbred strains of mice. , 1996, Bone.
[38] W H Harris,et al. Differential effects of different forms of hydroxyapatite and hydroxyapatite/tricalcium phosphate particulates on human monocyte/macrophages in vitro. , 1996, Journal of biomedical materials research.
[39] U. Ripamonti,et al. Expression of the osteogenic phenotype in porous hydroxyapatite implanted extraskeletally in baboons. , 1993, Matrix.
[40] N. Cullen,et al. Heterotopic ossification: pharmacologic options. , 2009, The Journal of head trauma rehabilitation.
[41] Huipin Yuan,et al. Osteoinduction and its evaluation , 2008 .
[42] B. Olsen,et al. Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. , 2005, Current topics in developmental biology.
[43] A. Kirkbride,et al. SINTERED POROUS HYDROXYAPATITES WITH INTRINSIC OSTEOINDUCTIVE ACTIVITY: GEOMETRIC INDUCTION OF BONE FORMATION , 1999 .
[44] H. Yamasaki,et al. Osteogenic response to porous hydroxyapatite ceramics under the skin of dogs. , 1992, Biomaterials.
[45] W. den Hollander,et al. Macroporous calcium phosphate bioceramics in dog femora: a histological study of interface and biodegradation. , 1989, Biomaterials.